
北美自动细胞计数器市场预测至 2028 年 - COVID-19 影响和区域分析 - 按类型(血细胞计数器、流式细胞仪、电阻抗库尔特计数器和分光光度计)和最终用户(医院、研究实验室、诊断中心、和别的)
No. of Pages: 151 | Report Code: BMIRE00027221 | Category: Life Sciences
No. of Pages: 151 | Report Code: BMIRE00027221 | Category: Life Sciences
北美自动化细胞计数器市场
预计将从2022年的29.0897亿美元增长到2028年的41.4638亿美元;预计 2022 年至 2028 年复合年增长率为 6.1%。
药物发现活动增加
生物技术与生物技术生物制药行业专注于发现和开发治疗各种疾病的药物。细胞和分子生物学已成为现代药物发现过程的重要组成部分。监测细胞和内部细胞活动的相互作用可以提供有关细胞健康、疾病状态变化以及靶标对潜在治疗化合物的反应的关键信息。在细胞水平上可视化生物活性的能力一直是药物发现的主要要素。此外,自动化和大容量筛选方法的增加允许测试许多化合物。监测各种化合物针对特定类型癌症的效果是在细胞水平上进行的。例如,自动细胞计数器用于监测癌症各个阶段的癌细胞特征的变化。此外,还举办了各种网络研讨会,以提高人们对各个机构用于细胞成像和细胞计数的技术的认识。例如,ATA Scientific Instruments 于 2020 年 10 月举办了四场新的网络研讨会,专门关注药物发现的细胞计数和成像。因此,药物发现和开发的增加正在推动对自动化细胞计数器的需求。
市场概览强>
北美自动细胞计数器市场分为美国、加拿大和墨西哥。市场增长归因于慢性病和传染病患病率的上升;对癌症、生物医学和干细胞的研究不断发展;政府发起的研发活动激增。据美国卫生与公众服务部称,“健康人民 2030”正在提高所有年龄段人群加强预防性护理的意识。教育儿童、成人和老年人定期进行筛查、常规健康检查和血液检查。因此,政府预防性医疗保健举措预计会增加美国的自动细胞计数器市场。
北美自动化细胞计数器
2028年市场收入及预测(百万美元)
北美自动化细胞计数器市场细分
  ;
北美自动细胞计数器市场根据类型、最终用户和国家/地区进行细分。根据类型,市场分为血细胞计数器、流式细胞仪、电阻抗库尔特计数器和分光光度计。分光光度计细分市场在 2022 年占据最大的市场份额。根据最终用户,市场分为医院、研究实验室、诊断中心等。 2022 年,医院细分市场占据最大的市场份额。根据国家/地区,市场分为美国、加拿大和墨西哥。美国在 2022 年占据主导市场份额。
Eppendorf;赛默飞世尔科技公司;计数星公司; Bio-Rad 实验室公司; F.霍夫曼-拉罗氏有限公司; Chemometec A/S;对齐遗传学;贝克曼库尔特公司(丹纳赫);纳米恩泰克;奥林巴斯公司;默克公司;希森美康公司;安捷伦科技公司;雅培;和 Nexcelom Bioscience LLC。是北美自动细胞计数器市场的领先公司。
Strategic insights for North America Automated Cell Counters involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 2,908.97 Million |
Market Size by 2028 | US$ 4,146.38 Million |
Global CAGR (2022 - 2028) | 6.1% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Automated Cell Counters refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Automated Cell Counters Market is valued at US$ 2,908.97 Million in 2022, it is projected to reach US$ 4,146.38 Million by 2028.
As per our report North America Automated Cell Counters Market, the market size is valued at US$ 2,908.97 Million in 2022, projecting it to reach US$ 4,146.38 Million by 2028. This translates to a CAGR of approximately 6.1% during the forecast period.
The North America Automated Cell Counters Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Automated Cell Counters Market report:
The North America Automated Cell Counters Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Automated Cell Counters Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Automated Cell Counters Market value chain can benefit from the information contained in a comprehensive market report.